[1] |
Lawton MT, Rutledge WC, Kim H, et al. Brain arteriovenous malformations[J]. Nat Rev Dis Primers, 2015, 1:15008.
doi: 10.1038/nrdp.2015.8
pmid: 27188382
|
[2] |
脑动静脉畸形介入治疗中国专家共识[J]. 中华神经外科杂志, 2017, 33(12):1195-1203.
|
[3] |
Wu EM, El AT, McDougall CM, et al. Embolization of brain arteriovenous malformations with intent to cure: A systematic review[J]. J Neurosurg, 2019, 132(2):388-399.
doi: 10.3171/2018.10.JNS181791
pmid: 30717053
|
[4] |
Solomon RA, Connolly EJ. Arteriovenous malformations of the brain[J]. N Engl J Med, 2017, 376(19):1859-1866.
doi: 10.1056/NEJMra1607407
URL
|
[5] |
Chen C, Ding D, Derdeyn CP, et al. Brain arteriovenous malformations: A review of natural history, pathobiology, and interventions[J]. Neurology, 2020, 95(20):917-927.
doi: 10.1212/WNL.0000000000010968
URL
|
[6] |
Hu J, Albadawi H, Chong BW, et al. Advances in biomaterials and technologies for vascular embolization[J]. Adv Mater, 2019, 31(33):e1901071.
|
[7] |
Haw CS terBrugge K, Willinsky R, et al. Complications of embolization of arteriovenous malformations of the brain[J]. J Neurosurg, 2006, 104(2):226-232.
pmid: 16509496
|
[8] |
Vollherbst DF, Chapot R, Bendszus M, et al. Glue, onyx, squid or PHIL Liquid embolic agents for the embolization of cerebral arteriovenous malformations and dural arteriovenous fistulas[J]. Clin Neuroradiol, 2022, 32(1):25-38.
doi: 10.1007/s00062-021-01066-6
|
[9] |
Ayad M, Eskioglu E, Mericle RA. Onyx: A unique neuroembolic agent[J]. Expert Rev Med Devices, 2006, 3(6):705-715.
doi: 10.1586/17434440.3.6.705
URL
|
[10] |
Rosen RJ, Contractor S. The use of cyanoacrylate adhesives in the management of congenital vascular malformations[J]. Semin Intervent Radiol, 2004, 21(1):59-66.
doi: 10.1055/s-2004-831406
URL
|
[11] |
Kuwayama K, Matsuda T, Hagino H, et al. A case of herpes encephalitis occurring after aneurysmal coil embolization[J]. J Neuroendovasc Ther, 2017, 11(12):619-624.
doi: 10.5797/jnet.cr.2017-0027
URL
|
[12] |
de Los RK, Patel A, Doshi A, et al. Seizures after Onyx embolization for the treatment of cerebral arteriovenous malformation[J]. Interv Neuroradiol, 2011, 17(3):331-338.
doi: 10.1177/159101991101700308
pmid: 22005695
|
[13] |
Sinha KR, Duckwiler G, Rootman DB. Urticarial reaction following endovascular embolization of an orbital arteriovenous malformation (AVM) with n-butyl cyanoacrylate (nBCA) glue[J]. Interv Neuroradiol, 2017, 23(6):666-668.
doi: 10.1177/1591019917728400
pmid: 28893128
|
[14] |
Lukic S, Jankovic S, Popovic KS, et al. Analysis of risk factors for perifocal oedema after endovascular embolization of unruptured intracranial arterial aneurysms[J]. Radiol Oncol, 2015, 49(4):341-346.
doi: 10.1515/raon-2015-0044
pmid: 26834520
|
[15] |
Tailor C, Ashby WS, Gorassini DR, et al. Embolized cerebral arteriovenous malformations: A multivariate analysis of 101 excised specimens[J]. J Neurosurg, 2019, 132(4):1140-1146.
doi: 10.3171/2018.12.JNS182244
URL
|
[16] |
Quinn JC, Mittal N, Baisre A, et al. Vascular inflammation with eosinophils after the use of n-butyl cyanoacrylate liquid embolic system[J]. J Neurointerv Surg, 2011, 3(1):21-24.
doi: 10.1136/jnis.2010.002501
pmid: 21990781
|
[17] |
Natarajan SK, Born D, Ghodke B, et al. Histopathological changes in brain arteriovenous malformations after embolization using Onyx or N-butyl cyanoacrylate. Laboratory investigation[J]. J Neurosurg, 2009, 111(1):105-113.
doi: 10.3171/2008.12.JNS08441
pmid: 19326974
|
[18] |
Mazal PR, Stichenwirth M, Gruber A, et al. Tissue reactions induced by different embolising agents in cerebral arteriovenous malformations: A histopathological follow-up[J]. Pathology, 2006, 38(1):28-32.
doi: 10.1080/00313020500455795
URL
|
[19] |
Vinters HV, Lundie MJ, Kaufmann JC. Long-term pathological follow-up of cerebral arteriovenous malformations treated by embolization with bucrylate[J]. N Engl J Med, 1986, 314(8):477-483.
doi: 10.1056/NEJM198602203140804
URL
|